CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 68 filers reported holding CYTOMX THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.30 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $334 | -98.3% | 259 | -98.0% | 0.00% | – |
| Q1 2023 | $19,706 | -78.1% | 13,050 | -76.8% | 0.00% | – |
| Q4 2022 | $90,050 | +23.4% | 56,281 | +11.3% | 0.00% | – |
| Q3 2022 | $73,000 | -28.4% | 50,586 | -9.4% | 0.00% | -100.0% |
| Q2 2022 | $102,000 | -11.3% | 55,846 | +208.5% | 0.00% | 0.0% |
| Q2 2021 | $115,000 | – | 18,101 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,877,148 | $13,853,000 | 1.46% |
| Congress Park Capital LLC | 167,811 | $1,238,000 | 1.04% |
| Perceptive Advisors | 3,253,923 | $24,014,000 | 0.65% |
| RTW INVESTMENTS, LP | 990,463 | $7,310,000 | 0.44% |
| Spark Investment Management LLC | 337,164 | $2,488,000 | 0.32% |
| Exane Asset Management | 54,065 | $399,000,000 | 0.31% |
| DAFNA Capital Management LLC | 100,000 | $738,000 | 0.28% |
| HARBOURVEST PARTNERS LLC | 79,193 | $584,000 | 0.24% |
| WELD CAPITAL MANAGEMENT LLC | 86,363 | $637,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 77,997 | $576,000 | 0.08% |